Prevail Innovative Wealth Advisors, LLC Cue Biopharma, Inc. Transaction History
Prevail Innovative Wealth Advisors, LLC
- $515 Billion
- Q3 2025
A detailed history of Prevail Innovative Wealth Advisors, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Prevail Innovative Wealth Advisors, LLC holds 18,987 shares of CUE stock, worth $11,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,987
Previous 18,987
-0.0%
Holding current value
$11,961
Previous $13 Million
5.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CUE
# of Institutions
53Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.3 Million1.28% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.43MShares$2.16 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$504,4830.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$476,7430.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $22.3M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...